CRIHX | NLSCX | CRIHX / NLSCX | |
Total Expense Ratio | 2.27 | 2.43 | 93% |
Annual Report Gross Expense Ratio | 2.43 | 2.43 | 100% |
Fund Existence | 9 years | 14 years | - |
Gain YTD | -3.181 | 5.709 | -56% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 1000 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 396M | 7.81B | 5% |
Annual Yield % from dividends | 0.96 | 0.00 | - |
Returns for 1 year | -7.19 | 7.41 | -97% |
Returns for 3 years | 13.80 | 18.58 | 74% |
Returns for 5 years | 14.71 | 18.21 | 81% |
Returns for 10 years | N/A | 44.34 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETCHX | 36.73 | 0.61 | +1.69% |
Eventide Healthcare & Life Sciences C | |||
VTIAX | 40.06 | 0.24 | +0.60% |
Vanguard Total Intl Stock Index Admiral | |||
HRSMX | 89.55 | 0.35 | +0.39% |
Hood River Small-Cap Growth Instl | |||
LICVX | 18.64 | 0.07 | +0.38% |
Lord Abbett International Equity R6 | |||
VESMX | 19.48 | 0.05 | +0.26% |
VELA Small Cap I |